Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/reperfusion Injury in Mice.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failure.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Loss of miRNA-153 promotes EndMT and compromises lung vascular integrity.

American journal of respiratory cell and molecular biology·2026
Same author

Co-localization analysis of spatial transcriptomics in ligand-receptor pairs from tumor microenvironment.

Critical reviews in oncology/hematology·2026
Same author

Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Nature communications·2026
Same author

Primary cilia promote resistance to EGFR tyrosine kinase inhibitor, osimertinib, in non-small cell lung cancer.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Sep 4, 2025

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
08:43

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

Published on: June 19, 2018

15.1K

PLCβ2 Promotes VEGF-Induced Vascular Permeability.

Kathryn N Phoenix1, Zhichao Yue2, Lixia Yue2

  • 1Center for Vascular Biology, Department of Cell Biology (K.N.P., K.P.C.), University of Connecticut Health Center, Farmington.

Arteriosclerosis, Thrombosis, and Vascular Biology
|July 21, 2022
PubMed
Summary

Phospholipase C beta 2 (PLCβ2) is a key regulator of vascular permeability, controlling calcium and lipid levels. Targeting PLCβ2 offers a novel therapeutic strategy for diseases involving abnormal vascular permeability.

Keywords:
homeostasisischemiapermeabilityreperfusionvascular endothelial growth factor A

More Related Videos

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

16.9K
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.8K

Related Experiment Videos

Last Updated: Sep 4, 2025

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
08:43

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

Published on: June 19, 2018

15.1K
The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

16.9K
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.8K

Area of Science:

  • Vascular Biology
  • Cell Signaling
  • Molecular Medicine

Background:

  • Vascular permeability is crucial for tissue homeostasis.
  • Vascular Endothelial Growth Factor (VEGF) significantly increases vascular permeability in various diseases.
  • Identifying new regulators of vascular permeability is essential for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of Phospholipase C beta 2 (PLCβ2) in VEGF-induced vascular permeability.
  • To elucidate the molecular mechanisms by which PLCβ2 regulates vascular permeability.
  • To evaluate the therapeutic potential of targeting PLCβ2 in disease models.

Main Methods:

  • Utilized in vitro and in vivo models of VEGF-induced vascular permeability.
  • Assessed intracellular calcium release and phosphatidylinositol 4,5-bisphosphate levels.
  • Employed global knockout mice and cell-based assays with PLCβ2 modulation.

Main Results:

  • Global knockout of PLCβ2 blocked VEGF-induced vascular permeability in mice and endothelial cells.
  • PLCβ2 deficiency reduced calcium flux and phosphatidylinositol 4,5-bisphosphate levels.
  • Loss of PLCβ2 improved outcomes in hyperoxia-induced lung injury and cardiac ischemia-reperfusion models.

Conclusions:

  • PLCβ2 is a critical positive regulator of VEGF-induced vascular permeability.
  • PLCβ2 regulates vascular permeability via calcium flux and phosphatidylinositol 4,5-bisphosphate signaling.
  • Targeting PLCβ2 presents a promising therapeutic avenue for managing vascular permeability disorders.